Cytek Biosciences, Inc.

NasdaqGS:CTKB Stock Report

Market Cap: US$623.3m

Cytek Biosciences Future Growth

Future criteria checks 4/6

Cytek Biosciences is forecast to grow earnings and revenue by 111.9% and 12.2% per annum respectively. EPS is expected to grow by 110.8% per annum. Return on equity is forecast to be 9.3% in 3 years.

Key information

111.9%

Earnings growth rate

110.8%

EPS growth rate

Life Sciences earnings growth17.5%
Revenue growth rate12.2%
Future return on equity9.3%
Analyst coverage

Good

Last updated03 Sep 2024

Recent future growth updates

Recent updates

Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Shares Not Telling The Full Story

Sep 13
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Shares Not Telling The Full Story

An Intrinsic Calculation For Cytek Biosciences, Inc. (NASDAQ:CTKB) Suggests It's 49% Undervalued

Aug 09
An Intrinsic Calculation For Cytek Biosciences, Inc. (NASDAQ:CTKB) Suggests It's 49% Undervalued

Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly?

Jul 12
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly?

Potential Upside For Cytek Biosciences, Inc. (NASDAQ:CTKB) Not Without Risk

Jun 04
Potential Upside For Cytek Biosciences, Inc. (NASDAQ:CTKB) Not Without Risk

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Mar 20

Cytek Biosciences' (NASDAQ:CTKB) Solid Profits Have Weak Fundamentals

Mar 08
Cytek Biosciences' (NASDAQ:CTKB) Solid Profits Have Weak Fundamentals

Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization Investments

Jul 27

Checking In On Cytek Biosciences

Mar 23

Earnings and Revenue Growth Forecasts

NasdaqGS:CTKB - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262649N/AN/A4
12/31/20252370N/AN/A6
12/31/2024204-12N/AN/A6
6/30/2024198-181115N/A
3/31/2024201-1216N/A
12/31/2023193-1205N/A
9/30/2023183-14-82N/A
6/30/2023176-6-11-1N/A
3/31/2023166-2-17-8N/A
12/31/20221642-22-12N/A
9/30/2022155-1-18-13N/A
6/30/2022148-3-9-4N/A
3/31/2022139-2-31N/A
12/31/2021128005N/A
9/30/20211201811N/A
6/30/20211102912N/A
3/31/20219941416N/A
12/31/20209331415N/A
12/31/201958-17-15-14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CTKB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: CTKB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CTKB is expected to become profitable in the next 3 years.

Revenue vs Market: CTKB's revenue (12.2% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: CTKB's revenue (12.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CTKB's Return on Equity is forecast to be low in 3 years time (9.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y